141 related articles for article (PubMed ID: 17313836)
21. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].
Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
23. Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M
Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589
[TBL] [Abstract][Full Text] [Related]
25. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
27. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
29. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
Uke M; Rekhi B; Ajit D; Jambhekar NA
Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
31. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
Donati V; Fontanini G; Dell'Omodarme M; Prati MC; Nuti S; Lucchi M; Mussi A; Fabbri M; Basolo F; Croce CM; Aqeilan RI
Clin Cancer Res; 2007 Feb; 13(3):884-91. PubMed ID: 17289881
[TBL] [Abstract][Full Text] [Related]
32. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
33. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
34. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
[TBL] [Abstract][Full Text] [Related]
35. Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar Protein Expression Profiles.
Egawa-Takata T; Yoshino K; Hiramatsu K; Nakagawa S; Serada S; Nakajima A; Endo H; Kubota S; Matsuzaki S; Kobayashi E; Ueda Y; Morii E; Inoue M; Naka T; Kimura T
Int J Gynecol Cancer; 2018 Nov; 28(9):1751-1757. PubMed ID: 30358701
[TBL] [Abstract][Full Text] [Related]
36. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
37. [Expression of placental growth factor and pigment epithelium-derived factor in non-small cell lung cancer and the prognostic significance thereof].
Zhang LJ; Chen JF; Lu AP; Ke Y; Mansel RE; Jiang WG
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3328-31. PubMed ID: 16409837
[TBL] [Abstract][Full Text] [Related]
38. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.
Fukuoka J; Fujii T; Shih JH; Dracheva T; Meerzaman D; Player A; Hong K; Settnek S; Gupta A; Buetow K; Hewitt S; Travis WD; Jen J
Clin Cancer Res; 2004 Jul; 10(13):4314-24. PubMed ID: 15240517
[TBL] [Abstract][Full Text] [Related]
39. Survivin gene expression in early-stage non-small cell lung cancer.
Falleni M; Pellegrini C; Marchetti A; Oprandi B; Buttitta F; Barassi F; Santambrogio L; Coggi G; Bosari S
J Pathol; 2003 Aug; 200(5):620-6. PubMed ID: 12898598
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
